Aehr Test Systems, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aehr Test Systems, Inc. ("Aehr" or "the Company") (NASDAQ:AEHR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated […]

Marqeta, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marqeta, Inc. ("Marqeta" or "the Company") (NASDAQ:MQ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Nextracker Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Regeneron Pharmaceuticals, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

MGPI Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against MGP Ingredients, Inc. (MGPI)

The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against MGP Ingredients, Inc.(“MGPI”) (NASDAQ: MGPI) on behalf of those who purchased or otherwise acquired MGPI common stock between May 4, 2023, and October 30, 2024, inclusive (the “Class Period”). The lead plaintiff deadline

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Kyverna Therapeutics, Inc. ("Kyverna" or "the Company") (NASDAQ:KYTX) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable

XRAY DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action – XRAY

NEW YORK CITY, NY / ACCESS Newswire / January 25, 2025 / WHY: New York, N.Y., January 25, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ:XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the "Class Period"), of theimportant January

BexBack Revolutionizes Crypto Trading: 100% Deposit Bonus, $50 Welcome Bonus, 100x Leverage and No KYC

SINGAPORE, Jan. 25, 2025 (GLOBE NEWSWIRE) — With Bitcoin prices stabilizing around $100,000, analysts predict a high-volatility phase in the market. To help traders seize this opportunity, BexBack Exchange introduces an exceptional promotional package: a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage on cryptocurrency trading. Plus, with a No

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA

(NASDAQ:BIOA), NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge's registration statement for the initial public offering conducted on September 26, 2024 (the “IPO”), of the important March 10, 2025 lead

Scroll to Top